mSphere is a leading open-access journal published by the American Society for Microbiology, dedicated to the dynamic fields of Microbiology and Molecular Biology. Since its inception in 2016, mSphere has rapidly established itself as a reputable source of scholarly research, achieving notable impact factors and excellence within the academic community. The journal ranks in the top quartile (Q1) amongst its peers in Microbiology, and Q2 in the field of Molecular Biology, demonstrating its significance and relevance through Scopus rankings—specifically, it holds the #42 spot out of 182 in the Microbiology category and #108 out of 410 in Molecular Biology. With an editorial commitment to advancing the understanding of microbial and molecular sciences, mSphere provides an accessible platform for researchers, professionals, and students alike to disseminate groundbreaking findings. The journal promotes rigorous peer-review and invites innovative contributions aimed at enhancing microbial research mobility and molecular exploration. Accessible openly since 2016, mSphere continues to thrive as an influential publication driving scientific dialogue and discovery in the microbiological sciences.

Welcome to the Journal of Microbiology Immunology and Infection, a premier academic publication established in 1998 and now proudly owned by Elsevier Taiwan. As an Open Access journal since 2016, it provides unrestricted access to groundbreaking research in the fields of immunology, microbiology, and infectious diseases, making it an essential resource for researchers, practitioners, and students alike. The journal holds impressive rankings, including Q1 status in categories such as Infectious Diseases and Microbiology (medical), and a notable 92nd percentile in its Scopus ranking for Medicine - Infectious Diseases. With a dedicated focus on advancing knowledge and fostering collaboration within the scientific community, the Journal of Microbiology Immunology and Infection is committed to publishing high-impact research that significantly influences practice and policy in healthcare and life sciences. The journal is also recognized for its contribution to the ongoing dialogue surrounding contemporary issues in immunology and infection, positioning it as a vital platform for scholarly exchange and innovation.

Mycology: An International Journal on Fungal Biology, published by Taylor & Francis Ltd, stands at the forefront of fungal research, facilitating the dissemination of knowledge across the diverse fields of infectious diseases, microbiology, and plant science. Established as an Open Access journal since 2010, it offers researchers free and immediate access to high-quality articles that advance our understanding of fungal biology and its applications. With a commendable ranking in Q2 for Infectious Diseases and Microbiology, and Q1 for Plant Science as of 2023, it positions itself as a vital resource for the global scientific community. The journal, conveniently located in the United Kingdom, is committed to publishing rigorous research that stimulates discussion and fosters collaboration among academics, practitioners, and students alike. By providing a platform for innovative studies and critical reviews, Mycology continues to play an essential role in unraveling the complexities of fungal organisms and their profound implications in health, agriculture, and ecosystem dynamics.

MYCOSES is a renowned academic journal published by Wiley, specializing in the fields of Dermatology, Infectious Diseases, and general Medicine, with a commendable focus on mycological research and its clinical implications. Established in 1957, this journal has significantly contributed to advancing our understanding of fungal diseases, offering a platform for high-quality research that ranks among the top in its categories—achieving Q1 status in Dermatology and Q1 in Medicine (miscellaneous), while maintaining a strong Q2 ranking in Infectious Diseases. With an impressive Scopus ranking of #5 in Medicine - Dermatology, MYCOSES occupies a pivotal position in the dissemination of critical findings and innovative practices within the scientific community. Although it is not an open-access journal, MYCOSES continues to attract a wide array of researchers, professionals, and students seeking to enhance their knowledge and keep abreast of the latest developments in mycology. Overall, MYCOSES not only serves as an essential resource for academia but also plays a vital role in shaping future research directions and clinical approaches to fungal infections.

Medical Mycology Journal is a leading publication in the field of medical mycology, dedicated to advancing the understanding and treatment of fungal infections. Published by the Japanese Society of Medical Mycology, this journal serves as an essential resource for researchers, clinicians, and students alike. With an ISSN of 2185-6486 and an E-ISSN of 2186-165X, it aims to provide high-quality peer-reviewed articles focusing on clinical and epidemiological studies, diagnosis, and novel therapeutic approaches related to fungal pathogens. Operating under a Q3 ranking in Infectious Diseases and having consistently published significant findings since its establishment in 2011, the journal is pivotal for those working at the intersection of mycology and infectious disease management. Although currently non-open access, the journal's insights are vital for expanding knowledge in this critical area of healthcare, addressing pressing global health challenges linked to fungal infections.

Fungal Diversity is a premier academic journal dedicated to advancing the science of mycology, encompassing ecological, evolutionary, and biological research involving fungi. Published by Springer, this journal has established a significant presence in the academic community since its inception in 1998, and it continues to thrive with a convergence period extending to 2024. Holding a prestigious Q1 ranking in several categories — including Ecology, Ecology, Evolution, Behavior and Systematics, and Plant Science — Fungal Diversity showcases cutting-edge research that influences ecological management, conservation, and biodiversity studies. With its notable positions in Scopus rankings, including being ranked #1 in Environmental Science - Ecology, the journal serves as an essential resource for researchers, professionals, and students interested in the complex interplay between fungi and their environments. Although it does not currently offer open access, interested readers can benefit from the journal's rich repository of peer-reviewed articles, making Fungal Diversity a vital component of the scientific literature landscape.

Fungal Biology, published by Elsevier Science Ltd, is a premier journal dedicated to advancing the field of mycology and its interdisciplinary applications. With an ISSN of 1878-6146 and E-ISSN 1878-6162, this journal serves as a vital platform for researchers and professionals interested in the ecological, evolutionary, and genetic aspects of fungi, as well as their implications in infectious diseases and plant sciences. As of 2023, it proudly holds a Q2 ranking in Ecology, Evolution, Behavior and Systematics and Plant Science, and a Q3 ranking in Genetics and Infectious Diseases, highlighting its significant contribution to these domains. The journal boasts an impressive Scopus rank, including a percentile of 83rd in Ecological studies, ensuring that published research reaches a wide audience and impacts ongoing discourse in the field. With open access options, Fungal Biology encourages the dissemination of high-quality research, aimed to foster collaboration and innovation among scholars and practitioners. With its convergence of knowledge from 2010 to 2024, this journal is instrumental for those advancing the understanding of fungal biology and its myriad applications in environmental and health sciences.

JOURNAL DE MYCOLOGIE MEDICALE is a premier publication in the field of infectious diseases, particularly focusing on the study of mycology and its clinical implications. Published by MASSON EDITEUR, this esteemed journal is based in France and has been disseminating valuable research since its inception in 1994. With an ISSN of 1156-5233 and an E-ISSN of 1773-0449, it plays a critical role in advancing knowledge in mycological infections, positioning itself in the Q3 category for infectious diseases as per the 2023 quartiles. As indicated by its ranking in Scopus, ranking #142 out of 344 in the medicine-infectious diseases category, the journal maintains a prominent presence within the academic community, appealing to researchers, healthcare professionals, and students alike. Although access options are not open access, the journal endeavors to promote a deeper understanding of mycological studies that are crucial for combating ongoing and emerging infectious threats. As it continues to converge on new findings up to 2024, JOURNAL DE MYCOLOGIE MEDICALE remains an essential resource for those invested in the critical intersections of mycology and medicine.

Research in Microbiology, published by Elsevier, is a prominent academic journal devoted to advancing the field of microbiology, encompassing a diverse array of topics including immunology, molecular biology, and biochemistry. Established in 1987, the journal has expanded its focus over the years, with a commendable impact factor reflecting its relevance and influence in the scientific community. Although it does not currently offer open access options, Research in Microbiology remains a crucial resource for researchers and professionals seeking to stay abreast of the latest findings and methodologies. The journal holds a respectable Q2 ranking in Medicine (miscellaneous) and a Q3 ranking in both Microbiology and Molecular Biology for 2023, highlighting its position within the scholarly landscape. With its base in France and accessible to a global audience, Research in Microbiology continues to foster scholarly exchange, making it an essential platform for the dissemination of impactful microbiological research.

Frontiers in Fungal Biology is an innovative academic journal dedicated to advancing the field of mycology and its interdisciplinary connections, published by FRONTIERS MEDIA SA. With an E-ISSN of 2673-6128, this journal focuses on exploring diverse aspects of fungal biology, including ecological roles, evolutionary processes, and interactions with other organisms. Since its inception in 2020, Frontiers in Fungal Biology has garnered attention within the scientific community, earning a commendable Q2 ranking in both Ecology, Evolution, Behavior and Systematics, and Environmental Science categories in 2023, alongside respectable Q3 rankings in Infectious Diseases and Microbiology. The journal is committed to open access principles, making cutting-edge research freely available to a global audience, promoting knowledge sharing and collaboration. By providing a platform for rigorous research and impactful discussions, Frontiers in Fungal Biology aims to enhance the understanding of fungi and their significant roles in ecosystems, health, and biotechnology, appealing to researchers, professionals, and students alike.